Cross-Market Price Comparison
| Other Listed Market | Shanghai (SSE) — 康德莱 |
|---|---|
| Other Market Stock Code | 603987 |
| H-Share Offer Price | To be extracted |
| Other Market Price | Loading... |
| Reference Exchange Rate | Loading... |
| H-Share Offer Price Premium/Discount vs Other Market | Loading... |
Company Overview
| Stock Name | 上海康德萊醫療器械股份有限公司 - Ｈ股 |
|---|---|
| Stock Code | 01501 |
| Company Full Name | 上海康德萊醫療器械股份有限公司 - Ｈ股 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事介植入醫療器械的研發、制造及銷售，當中專注於心內介入醫療器械。 |
| Listing Date | 2019-11-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市嘉定區金園一路925號2幢 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.int-medical.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 20.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 28.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 416,000,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 27.0 |
|---|---|
| First Day Open | HK$ 27.0 |
| First Day Change | 29.81% |
| First Day Volume | 32637500.0 |
| First Day Turnover | 899357000.0 |
Use of Proceeds
| Use of Proceeds | 1、凈所得款項中的約34.1%或258.5百萬港元，擬用于建設位于上海市嘉定區的研發中心及其他設施； 2、凈所得款項中的約14.4%或109.2百萬港元，將用于開發現有管線產品并將其商業化，以及進一步拓展其產品供應； 3、凈所得款項中的約13.8%或104.6百萬港元，將用于購買額外生產設備并替換現有生產設備及將生產線自動化； 4、凈所得款項中的約8.7%或65.9百萬港元，將用于擴大其分銷網絡及覆蓋范圍、與當地分銷商的合作及加大營銷力度； 5、凈所得款項中的約19.6%或148.6百萬港元，將用于為潛在戰略投資（包括收購、合伙及外部授權）提供資金； 6、凈所得款項中的約9.4%或71.2百萬港元，將用于一般企業用途和為其營運資金提供資金。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
BOCOM International (Asia) Limited CE API271
Overall Coordinators (2)
交银国际证券有限公司 CE APJ121
招银国际融资有限公司 CE AVM940
Joint Bookrunners (2)
交银国际证券有限公司 CE APJ121
招银国际融资有限公司 CE AVM940
Joint Lead Managers (2)
交银国际证券有限公司 CE APJ121
招银国际融资有限公司 CE AVM940
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Worldwide Healthcare Trust PLC | 235,306,240 HKD | — | 28.28% | — | 6 months | 2020-05-08 |
Directors & Management
| Chairman | 梁棟科 |
|---|---|
| Company Secretary | 宋媛,梁瑞冰 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 上海康德萊企業發展集團股份有限公司(25.51%);梁棟科(8.30%);OrbiMed Capital LLC(6.83%);寧波懷格泰益股權投資合伙企業(有限合伙)(5.86%) |
|---|
